| Description | 1
Day Price Change %  | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | 0.94 | 2277.8B | 17.54 | 14.91 | 2.11 | 0.78 | 9.91 | 12.19 | 76.82 |
| Industry: Drug Manufacturers - Major (More Info) | 1.12 | 1104.9B | 14.40 | 21.50 | 3.60 | 0.56 | 9.30 | 18.30 | 84.10 |
| Companies | |||||||||
| Inhibiton Therapeutics, Inc. (IHBT.OB) | -20.00 | 1.4M | NA | NA | NA | NA | NA | NA | -20.56 |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -3.43 | 53.3M | NA | -29.99 | NA | NA | 1.00 | 51.64 | 9.77 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | -3.20 | 62.1M | NA | -75.18 | NA | NA | 4.96 | NA | -17.83 |
| Minrad International Inc. (BUF) | -2.86 | 83.8M | NA | -144.98 | NA | 4.72 | 9.39 | -281.41 | -6.10 |
| Oscient Pharmaceuticals Corp. (OSCI) | -0.88 | 16.1M | NA | NA | NA | NA | NA | -82.75 | -2.20 |
| APP Pharmaceuticals, Inc. (APPX) | -0.34 | 3.8B | 114.66 | 14.99 | NA | NA | NA | 12.07 | 329.77 |
| Chem Rx Corporation (CHRX.OB) | 0.00 | 55.2M | 62.50 | 1.79 | NA | 2.02 | 0.83 | -0.30 | 8.14 |
| CPEX Pharmaceuticals, Inc. (CPEX) | 0.00 | 41.2M | NA | NA | NA | NA | 1.92 | -42.73 | -31.80 |
| Javelin Pharmaceuticals, Inc. (JAV) | 0.00 | 170.3M | NA | -78.54 | NA | NA | 3.90 | NA | -27.00 |
| Quick-Med Technologies Inc. (QMDT.OB) | 0.00 | 7.7M | NA | NA | NA | NA | NA | -146.70 | -28.32 |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | 0.00 | 4.8M | NA | NA | NA | NA | NA | NA | 65.11 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.2M | NA | NA | NA | NA | NA | NA | NA |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 19.9M | NA | NA | NA | NA | 9.89 | NA | -53.08 |
| Eli Lilly & Co. (LLY) | 0.09 | 53.3B | 13.48 | 28.93 | 4.00 | 0.31 | 3.62 | 18.62 | 35.86 |
| WuXi PharmaTech (Cayman) Inc. (WX) | 0.11 | 1.1B | 32.53 | 22.82 | NA | 0.17 | 3.63 | 12.03 | NA |
| Johnson & Johnson (JNJ) | 0.28 | 199.6B | 17.33 | 26.46 | 2.60 | 0.30 | 4.30 | 20.23 | 152.41 |
| Bristol-Myers Squibb Co. (BMY) | 0.56 | 42.7B | 19.60 | 20.03 | 5.80 | 0.73 | 3.96 | 14.68 | NA |
| AstraZeneca plc (AZN) | 0.80 | 71.5B | 12.59 | 37.20 | 2.30 | 0.93 | 4.48 | 20.36 | 55.58 |
| Pfizer Inc. (PFE) | 1.00 | 129.9B | 14.49 | 13.45 | 6.70 | 0.25 | 1.95 | 22.89 | 31.90 |
| GeoPharma Inc. (GORX) | 1.02 | 32.5M | NA | -29.09 | NA | 0.83 | 1.01 | -13.06 | 10.41 |
| Glaxosmithkline plc (GSK) | 1.07 | 121.4B | 14.02 | 54.40 | 4.50 | 1.84 | 8.90 | 21.89 | 130.13 |
| Novogen Limited (NVGN) | 1.27 | 139.5M | NA | -41.62 | NA | NA | 3.88 | -140.78 | -39.95 |
| Wyeth (WYE) | 1.36 | 57.7B | 13.08 | 24.92 | 2.60 | 0.58 | 2.92 | 18.87 | 49.75 |
| Novartis AG (NVS) | 1.39 | 126.8B | 10.41 | 14.80 | 2.70 | 0.21 | 2.46 | 20.46 | 137.50 |
| Abbott Laboratories (ABT) | 1.78 | 90.6B | 21.91 | 24.38 | 2.50 | 0.73 | 4.78 | 18.07 | 143.30 |
| Merck & Co. Inc. (MRK) | 1.88 | 78.0B | 16.01 | 25.00 | 4.30 | 0.25 | 3.85 | 29.22 | 164.45 |
| Sanofi-Aventis (SNY) | 1.99 | 93.5B | 13.17 | 11.29 | 3.20 | 0.16 | 1.54 | 6.77 | NA |
| AP Pharma Inc. (APPA) | 2.05 | 46.0M | NA | -84.01 | NA | NA | 2.68 | NA | -10.61 |
| Schering-Plough Corp. (SGP) | 2.51 | 32.6B | NA | -18.30 | 1.30 | 0.83 | 3.68 | 8.86 | 51.69 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 4.46 | 873.2M | NA | -72.84 | NA | 0.01 | 5.38 | NA | -46.22 |
| Evotec AG (EVTC) | 4.62 | 419.0M | NA | -30.30 | NA | 0.06 | 1.48 | -166.79 | -84.45 |
| Aceto Corp. (ACET) | 5.24 | 201.1M | 21.05 | 7.58 | 2.60 | 0.00 | 1.50 | 3.35 | -18.62 |
| Keryx Biopharmaceuticals Inc. (KERX) | 5.88 | 24.3M | NA | -195.25 | NA | NA | 4.70 | NA | -6.83 |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | 6.25 | 8.0M | NA | NA | NA | NA | NA | NA | -5.16 |
| HST Global, Inc. (HSTC.OB) | 9.29 | NA | NA | NA | NA | NA | NA | NA | NA |
| Neurologix Inc. (NRGX.OB) | 15.38 | 20.8M | NA | -44.27 | NA | NA | 0.94 | NA | -18.52 |
| Avigen Inc. (AVGN) | 18.05 | 122.6M | NA | -40.98 | NA | 0.12 | 2.17 | NA | -26.63 |